This conference presented the first systematic and comprehensive recommendations and analysis on protecting human participants in research on nanomedicine products, including drugs, devices, and gene therapy using nano-vectors. Nanomedicine research in human subjects is at the forefront of new challenges to research ethics and oversight posed by advanced technologies. This research raises significant questions about how to protect human subjects, especially in first-in-human (FIH) trials.
Wednesday, April 25, 2012 - 11:30am to 1:00pm
St. Paul Student Center Theater
Prof. Robert Brackett, PhD
Illinois Institute of Technology
Tuesday, February 28, 2012 - 12:30pm to 2:00pm
Cowles Auditorium, Hubert H. Humphrey School of Public Affairs